Literature DB >> 2351644

Toxicity assessment of papaverine hydrochloride and papaverine-derived metabolites in primary cultures of rat hepatocytes.

J C Davila1, C G Reddy, P J Davis, D Acosta.   

Abstract

The present study was undertaken to assess and compare the toxic effects of papaverine hydrochloride and its metabolites. Primary cell cultures of rat hepatocytes were treated with papaverine (papaver), 3'-O-desmethyl (3'-OH), 4'-O-desmethyl (4'-OH), and 6-O-desmethyl (6-OH) papaverine at 1 x 10(-5), 1 x 10(-4), and 1 x 10(-3) M for 4, 8, 12, and 24-h periods. Cell injury was determined by: a) cell viability using the trypan blue exclusion test; b) cytosolic enzyme leakage of lactate dehydrogenase and aspartate aminotransferase; c) morphologic alterations; and d) lactate:pyruvate (L:P) ratios. Cell cultures showed concentration- and time-dependent toxic responses. For example, a decrease in cell viability and an increase in enzyme leakage were observed after cell treatment with 1 x 10(-4) and 1 x 10(-3) M papaver for 8 h; 1 x 10(-3) M 6-OH papaverine for 8 h and 1 x 10(-4) M for 24 h; and 1 x 10(-3) M 4'-OH papaverine for 24 h (P less than 0.05). Furthermore, changes in morphology correlated to cell viability and enzyme release in those cultures treated with papaver, 4'-OH and 6-OH papaverine. Some of these changes included size deformation, cell detachment from the dishes, and cell necrosis. On the other hand, an increase in L:P ratios (P less than 0.05) was detected with papaver as early as 8 h with 1 x 10(-4) and 1 x 10(-3) M and 12 h with 1 x 10(-5) M; 6-OH showed an increase in L:P ratios at 8 h with 1 x 10(-3) M and 12 h with 1 x 10(-4) M; these changes were evident with with 4'-OH at 12 h with 1 x 10(-3) M. In contrast, cells treated with 3'-OH papaverine did not show significant damage with any time period and concentration used in this study. The results of this study indicate that papaverine-derived metabolites are less cytotoxic than its parent compound, papaver. The toxicity was ranked as follows: papaver greater than 6-OH greater than 4'-OH greater than -3'-OH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351644     DOI: 10.1007/bf02624095

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  34 in total

Review 1.  In vitro screens from CNS, liver and kidney for systemic toxicity.

Authors:  C A Tyson; N H Stacey
Journal:  Toxicol Ind Health       Date:  1989-01       Impact factor: 2.273

2.  Inhibition of cytomegalovirus replication by smooth-muscle relaxing agents.

Authors:  T Albrecht; C H Lee; D J Speelman; O S Steinsland
Journal:  Proc Soc Exp Biol Med       Date:  1987-10

3.  Inhibitory effect of papaverine on HIV replication in vitro.

Authors:  A Turano; G Scura; A Caruso; C Bonfanti; R Luzzati; D Bassetti; N Manca
Journal:  AIDS Res Hum Retroviruses       Date:  1989-04       Impact factor: 2.205

4.  GLC determination of papaverine in biological fluids.

Authors:  D E Guttman; H B Kostenbauder; G R Wilkinson; P H Dubé
Journal:  J Pharm Sci       Date:  1974-10       Impact factor: 3.534

5.  Metabolism of [14C] papaverine in man.

Authors:  G Wilén; P Ylitalo
Journal:  J Pharm Pharmacol       Date:  1982-04       Impact factor: 3.765

6.  An in vitro approach to the study of target organ toxicity of drugs and chemicals.

Authors:  D Acosta; E M Sorensen; D C Anuforo; D B Mitchell; K Ramos; K S Santone; M A Smith
Journal:  In Vitro Cell Dev Biol       Date:  1985-09

7.  Metabolism of papaverine. I. Identification of metabolites in rat bile.

Authors:  F M Belpaire; M G Bogaert; M T Rosseel; M Anteunis
Journal:  Xenobiotica       Date:  1975-07       Impact factor: 1.908

8.  Metabolism of papaverine. II. Species differences.

Authors:  F M Belpaire; M G Bogaert
Journal:  Xenobiotica       Date:  1975-07       Impact factor: 1.908

9.  Protective effect of flavonoids on drug-induced hepatotoxicity in vitro.

Authors:  J C Davila; A Lenherr; D Acosta
Journal:  Toxicology       Date:  1989-08       Impact factor: 4.221

10.  Papaverine-induced chronic liver disease.

Authors:  E Poncin; C Silvain; G Touchard; J Barbier; M Beauchant
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

View more
  1 in total

1.  Papaverine, an opium alkaloid influences hepatic and pulmonary glutathione S-transferase activity and glutathione content in rats.

Authors:  Ritu Aneja; Archana Sharma; Anita Talwar; Sujata K Dass; Ramesh Chandra
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.